Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biological Effects of Radiation02:59

Biological Effects of Radiation

All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they produce ions...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meningeal immunity and "Interstitial" therapy: a new paradigm for immunotherapy in glioblastoma.

Frontiers in immunology·2026
Same author

Reply.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Multi-indicator assessment and probabilistic human health risks of heavy metals in rice and soils system in Eastern China.

Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering·2026
Same author

Trigeminal somatosensory evoked potentials for intraoperative monitoring and prognostic prediction in microvascular decompression for trigeminal neuralgia: a prospective cohort study.

Frontiers in neurology·2026
Same author

Laparoscopic and robotic extravascular stenting of the left renal vein for anterior nutcracker syndrome in a single-center series.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Enhanced positronium lifetime imaging through two-component reconstruction in time-of-flight positron emission tomography.

Frontiers in physics·2026

Related Experiment Video

Updated: May 7, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Information-theoretic model-averaged benchmark dose analysis in environmental risk assessment.

Walter W Piegorsch1, Lingling An, Alissa A Wickens

  • 1Interdisciplinary Program in Statistics, University of Arizona, Tucson, AZ, USA.

Environmetrics
|September 17, 2013
PubMed
Summary

This study introduces a model averaging approach to estimate Benchmark Doses (BMDs) for environmental risk assessment. This method improves low-dose exposure estimations, enhancing public health planning and regulatory decisions for hazardous agents.

Keywords:
Akaike information criterion (AIC)dose-response modelingfrequentist model averagingmodel uncertaintymulti-model inference

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Related Experiment Videos

Last Updated: May 7, 2026

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
10:33

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation

Published on: September 4, 2017

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing
09:29

An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing

Published on: May 13, 2020

Area of Science:

  • Environmental Science
  • Toxicology
  • Biostatistics

Background:

  • Accurate estimation of Benchmark Doses (BMDs) is crucial for environmental risk assessment, particularly at low exposure levels.
  • Traditional parametric models for dose-response relationships are sensitive to model misspecification, potentially leading to inaccurate low-dose inferences.
  • Benchmark Dose (BMD) technology aims to mitigate the impact of model selection uncertainty.

Purpose of the Study:

  • To apply a frequentist model averaging approach for estimating BMDs.
  • To develop and evaluate one-sided lower confidence limits on BMDs using this methodology.
  • To assess the small-sample properties of the confidence limits through simulation.

Main Methods:

  • Frequentist model averaging approach utilizing information-theoretic weights.
  • Construction of one-sided lower confidence limits for BMD estimation.
  • Simulation studies to analyze the small-sample properties of the confidence limits.

Main Results:

  • The model averaging approach provides a robust method for estimating BMDs, reducing sensitivity to parametric model choice.
  • The developed confidence limits demonstrate reliable performance in small-sample scenarios.
  • Application to environmental carcinogenicity data illustrates the practical utility of the methodology.

Conclusions:

  • Information-theoretic model averaging offers an improved strategy for benchmark dose analysis.
  • This methodology enhances environmental health planning and risk regulation for low-level hazardous agent exposures.
  • The approach provides more reliable low-dose inferences compared to traditional parametric methods.